Staged Kidney Transplantation During Combined Heart/Kidney Transplantation

Launched by CEDARS-SINAI MEDICAL CENTER · Mar 10, 2025

Keywords

ClinConnect Summary

This clinical trial is looking into a new way to perform kidney transplants for patients who also need heart transplants. The main goal is to see if a technique called ex vivo machine perfusion, which helps keep the kidney healthy before it’s implanted, can make the surgery safer and more effective. Participants will be adults aged 18 and older who are planning to have both a heart and kidney transplant at Cedars-Sinai Medical Center. However, those who need both organs transplanted in a single surgery for medical reasons won't be included in this study.

If you qualify and choose to participate, you will be part of a pioneering approach to transplantation that could lead to better outcomes for patients like you. The trial is not yet recruiting participants, so there is still time to learn more and consider whether this option is right for you or your loved one. Your health care team will provide you with all the details you need to understand what to expect during the trial and how it may benefit you.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Adult patients (18 years or older) undergoing combined heart and kidney transplantation at Cedars-Sinai Medical Center.
• Exclusion Criteria:
• • Patients who undergo simultaneous heart/kidney transplantation in a single operative event due to medical necessity will be excluded.
• • Patients with medical records flagged as "break-the-glass" or "research opt-out" within the center's electronic health record.